NCDR

NCDR
Name	NCDR
Type	Clinical registry consortium
Founded	1997
Headquarters	United States
Parent organization	American College of Cardiology

NCDR The NCDR is a suite of clinical registries and quality-improvement programs focused on cardiovascular care. It aggregates procedure-level and longitudinal data to support performance measurement, guideline implementation, and outcomes research across hospitals, health systems, and specialty practices. Stakeholders include professional societies, academic centers, government agencies, industry partners, and payer organizations.

Overview

The program links to national initiatives and institutions such as the American College of Cardiology, Centers for Medicare & Medicaid Services, Agency for Healthcare Research and Quality, Institute of Medicine, American Heart Association, and National Institutes of Health. It interfaces with hospital systems represented by organizations like Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Stanford Health Care. The platform supports clinical pathways and guidelines from groups such as Society for Cardiovascular Angiography and Interventions, Heart Failure Society of America, and European Society of Cardiology. Regulatory and policy intersections involve entities like Food and Drug Administration, Office of the National Coordinator for Health Information Technology, Joint Commission, and Centers for Disease Control and Prevention.

Structure and Governance

Governance involves professional bodies including American College of Cardiology Foundation, Board of Trustees, and advisory panels with representatives from AcademyHealth, Society of Thoracic Surgeons, American Association of Cardiovascular and Pulmonary Rehabilitation, and academic institutions such as Harvard Medical School, University of Pennsylvania, University of California, San Francisco, and Yale School of Medicine. Data oversight and ethics consults draw from committees linked to Institutional Review Board structures at centers like Brigham and Women's Hospital and University of Michigan Health System. Financial and contractual arrangements engage vendors and partners including Cerner Corporation, Epic Systems Corporation, IQVIA, and Duke University Health System.

Data Collection and Methodology

Data elements align with standards promulgated by Health Level Seven International, Logical Observation Identifiers Names and Codes, Current Procedural Terminology, and frameworks used by Allscripts, Meditech, and McKesson Corporation. Case definitions and variable dictionaries reflect guidance from World Health Organization, RAND Corporation, and consensus statements from specialty groups such as American College of Physicians and European Association of Percutaneous Cardiovascular Interventions. Risk adjustment and statistical methods reference approaches from Harvard School of Public Health, Johns Hopkins Bloomberg School of Public Health, Stanford University School of Medicine, and modeling techniques used in publications in The New England Journal of Medicine, Journal of the American Medical Association, and Circulation. Data capture integrates with registries and datasets like Get With The Guidelines, National Surgical Quality Improvement Program, Optum, MarketScan, and Medicare Fee-for-Service claims.

Major Registries and Programs

Core programs mirror registries maintained in collaboration with clinical societies: interventional cohorts involving procedures referenced by Society for Cardiovascular Angiography and Interventions and devices reviewed by Food and Drug Administration post-market surveillance; electrophysiology and implantable devices aligned with guidance from Heart Rhythm Society; structural heart programs interacting with registries used by Transcatheter Valve Therapy initiatives; heart failure modules that coordinate with American Heart Association initiatives and trial networks coordinated by National Heart, Lung, and Blood Institute; and surgical registries that interface with Society of Thoracic Surgeons datasets. Participation by health systems such as Kaiser Permanente, Intermountain Healthcare, Geisinger Health System, Montefiore Medical Center, and University of Pittsburgh Medical Center enables benchmarking across institutions.

Research, Quality Improvement, and Impact

Peer-reviewed research using the dataset appears in journals including The Lancet, The BMJ, European Heart Journal, JAMA Cardiology, and Annals of Internal Medicine and involves investigators from Duke Clinical Research Institute, Brigham and Women's Hospital, Vanderbilt University Medical Center, Columbia University Irving Medical Center, and Northwestern University Feinberg School of Medicine. Quality improvement collaboratives draw on methods from Institute for Healthcare Improvement, The Joint Commission, and national campaigns like Million Hearts. Health policy analyses incorporate metrics used by MedPAC, Congressional Budget Office, and state-level departments such as the New York State Department of Health and California Department of Public Health.

Privacy, Security, and Data Access

Privacy frameworks reference federal statutes and agencies including Health Insurance Portability and Accountability Act, Office for Civil Rights (United States Department of Health and Human Services), National Institute of Standards and Technology, and guidance from Electronic Frontier Foundation on data stewardship. Data security and de-identification practices are informed by standards from NIST Special Publication 800-53 and interoperability efforts led by FHIR (Fast Healthcare Interoperability Resources), Direct Project, and Commonwell Health Alliance. Data use agreements and research access processes involve institutional partners such as University of California, Icahn School of Medicine at Mount Sinai, and Emory University School of Medicine.

Criticisms and Controversies

Critiques echo debates seen in work involving ProPublica and reporting by outlets such as The New York Times and The Wall Street Journal about transparency, case-mix adjustment, and public reporting. Methodological controversies parallel discussions in panels convened by National Academies of Sciences, Engineering, and Medicine, Brookings Institution, and The Commonwealth Fund regarding performance measurement, selection bias, and commercial use of clinical data. Legal and ethical disputes touch institutions like State Attorneys General and litigation referenced in cases involving class action lawsuits over data sharing and consent. Critics cite concerns similar to those raised about registry-based research in analyses by Institute of Medicine committees and policy reports from Office of the Inspector General (HHS).

Category:Clinical registries